Business
Stocks in news: Trent, BPCL, Bajaj Finance, Mankind Pharma, Apollo Tyres
Analysts say the sharp surge in the Nifty suggests a potential shift in the near-term trend after the Budget-related sell-off, as the index has reclaimed its key moving averages.
In today’s trade, shares of Trent, BPCL, Bajaj Finance, Mankind Pharma, Apollo Tyres among others will be in focus due to various news developments and third quarter results.
Trent, NHPC, Tube Investments, Hexaware Technologies, Apollo Tyres
Shares of Trent, NHPC, Tube Investments, Hexaware Technologies and Apollo Tyres will be in focus as the companies will announce their third quarter results today.
BPCL
State-run refiner Bharat Petroleum (BPCL) has raised its capital expenditure plan for the coming fiscal year by 35% to Rs 25,000 crore, driven by an aggressive push into petrochemicals, even as peers Indian Oil and ONGC have trimmed their investment budgets.
Bajaj Finance
Bajaj Finance on Tuesday reported a 6% year-on-year (YoY) decline in its consolidated net profit for the third quarter at Rs 4,066 crore. The drop in bottomline was mainly due to an accelerated ECL provision and one-time charge of new labour codes. Adjusted for the above and tax, the profit grew 23% to Rs 5,317 crore.Pidilite Industries
Pidilite Industries on Tuesday reported 12% rise in consolidated net profit at Rs 624 crore for the third quarter ended December 2025. The company had posted a profit of Rs 557 crore in the third quarter last fiscal, Pidilite Industries, manufacturer of adhesives, sealants and construction chemicals.
AB Capital
Aditya Birla Capital reported a 33% jump in its December quarter consolidated net profit at Rs 945 crore compared to Rs 708 crore reported in the year ago period. The profit after tax (PAT) is attributable to the owners of the company.
Mankind Pharma
Indian drugmaker Mankind Pharma reported a higher third-quarter profit on Tuesday, driven by strong domestic demand for its drugs used for treating long-term illnesses. The company, which makes Gas-O-Fast antacid tablet and Manforce condoms, said its consolidated net profit climbed to Rs 409 crore ($45.3 million) for the quarter ended December 31, from Rs 380 crore.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)